PIK3CB and acute myeloid leukemia: Interestingly, our group has shown that activation of BM-MSC by AML co-culture is not inhibited by the pan-PI3K inhibitor LY294002 [73], thus suggesting that PI3K inhibition in the context of the malignant BMM will not have adverse effects on the surrounding environment.